Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (31)
Fabio Farinati & Filippo Pelizzaro. (2024) Gastric cancer screening in Western countries: A call to action. Digestive and Liver Disease.
Crossref
Crossref
Paulius Jonaitis, Juozas Kupcinskas, Javier P. Gisbert & Laimas Jonaitis. (2024) Helicobacter pylori Eradication Treatment in Older Patients. Drugs & Aging 41:2, pages 141-151.
Crossref
Crossref
Yan-Meng Wang, Mo-Ye Chen, Jing Chen, Xin-He Zhang, Yan Feng, Yu-Xi Han & Yi-Ling Li. (2024)
Success of susceptibility-guided eradication of
Helicobacter pylori
in a region with high secondary clarithromycin and levofloxacin resistance rates
. World Journal of Gastroenterology 30:2, pages 184-195.
Crossref
Crossref
Jianzhong Zhang. 2024. Molecular Medical Microbiology. Molecular Medical Microbiology
1133
1159
.
Akiko Kowada. (2022) A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening. Digestive Diseases and Sciences 68:5, pages 1735-1746.
Crossref
Crossref
Robert J. Huang, Monika Laszkowska, Haejin In, Joo Ha Hwang & Meira Epplein. (2023) Controlling Gastric Cancer in a World of Heterogeneous Risk. Gastroenterology 164:5, pages 736-751.
Crossref
Crossref
Jiafeng Zhang, Yuchen Deng, Chang Liu, Huiquan Wang, Heifei Ren, Sai Chen, Lei Chen, Bin Shi & Lin Zhou. (2023)
‘Family-based’ strategy for
Helicobacter pylori
infection screening: an efficient alternative to ‘test and treat’ strategy
. Gut, pages gutjnl-2023-329696.
Crossref
Crossref
Jannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, Stergios A. Polyzos, Christos Zavos, Evangelos Kazakos, Stergios Arapoglou, Foteini Kyrailidi, Maria C. Mouratidou, Marina Boziki & Elisabeth Vardaka. (2023) Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration. Medicina 59:3, pages 504.
Crossref
Crossref
Miao Duan, Yueyue Li, Jing Liu, Wenlin Zhang, Yi Dong, Zhongxue Han, Meng Wan, Minjuan Lin, Boshen Lin, Qingzhou Kong, Yuming Ding, Xiaoyun Yang, Xiuli Zuo & Yanqing Li. (2023)
Transmission routes and patterns of
helicobacter pylori
. Helicobacter 28:1.
Crossref
Crossref
Yun Zhang, Xinyi Feng, Lijun Bian, Yan Zhang, Qian Li, Yemin Xu, Qiang She, Caiwang Yan, Guotao Lu, Jian Wu, Weiming Xiao, Yanbing Ding & Bin Deng. (2023) Antibiotic Resistance of Helicobacter pylori and Related Risk Factors in Yangzhou, China: A Cross-Sectional Study. Journal of Clinical Medicine 12:3, pages 816.
Crossref
Crossref
Fahad Alsohaibani, Musthafa Peedikayil, Abdulaziz Alshahrani, Ali Somily, Raed Alsulaiman, Nahla Azzam & Majid Almadi. (2023) Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. Saudi Journal of Gastroenterology 29:6, pages 326-346.
Crossref
Crossref
Yi Hu, Yin Zhu & Nong-Hua Lu. (2022) The management of Helicobacter pylori infection and prevention and control of gastric cancer in China. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Zixing Wang, Wei Han, Fang Xue, Yujie Zhao, Peng Wu, Yali Chen, Cuihong Yang, Wentao Gu & Jingmei Jiang. (2022) Nationwide gastric cancer prevention in China, 2021–2035: a decision analysis on effect, affordability and cost-effectiveness optimisation. Gut 71:12, pages 2391-2400.
Crossref
Crossref
Yan Gong, Yi Luo, Zhilai Chen, Ying Sui & Yansong Zheng. (2022)
Longitudinal analysis of factors related to
Helicobacter pylori
infection in Chinese adults
. Open Medicine 17:1, pages 1742-1749.
Crossref
Crossref
Yujing Wang, Yu Xiang, Oulan Liao, Yaoyi Wu, Yan Li, Qin Du & Jun Ye. (2022)
Short-term outcomes and intermediate-term follow-up of
Helicobacter pylori
infection treatment for naïve patients: a retrospective observational study
. BMJ Open 12:9, pages e062096.
Crossref
Crossref
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez & F. Bosques-Padilla. (2022) Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: Is it possible to change that paradigm using modern molecular methods?. Revista de Gastroenterología de México (English Edition) 87:3, pages 330-341.
Crossref
Crossref
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez & F. Bosques-Padilla. (2022) Tratamiento empírico vs tratamiento basado en susceptibilidad para erradicar H.pylori: ¿es posible cambiar este paradigma usando métodos moleculares modernos?. Revista de Gastroenterología de México 87:3, pages 330-341.
Crossref
Crossref
Zhiqiang Song, Ye Chen, Hong Lu, Zhirong Zeng, Weihong Wang, Xiaofeng Liu, Guoxin Zhang, Qin Du, Xingzhou Xia, Changping Li, Shulin Jiang, Ting Wu, Peiyuan Li, Shuixiang He, Yin Zhu, Guiying Zhang, Jianming Xu, Yan Li, Lijuan Huo, Chunhui Lan, Yinglei Miao, Haixing Jiang, Ping Chen, Lijun Shi, Biguang Tuo, Dekui Zhang, Kui Jiang, Jiangbin Wang, Ping Yao, Xiaoxi Huang, Shaoqi Yang, Xuehong Wang & Liya Zhou. (2022)
Diagnosis and treatment of
Helicobacter pylori
infection by physicians in China: A nationwide cross‐sectional study
. Helicobacter 27:3.
Crossref
Crossref
Akiko Kowada & Masahiro Asaka. (2022)
Economic and health impacts of
Helicobacter pylori
eradication strategy for the treatment of peptic ulcer disease: A cost‐effectiveness analysis
. Helicobacter 27:3.
Crossref
Crossref
Huixia Chen, Hui Xie, Dong Shao, Liju Chen, Siyu Chen, Lin Wang & Xiao Han. (2022)
Oral Microbiota, a Potential Determinant for the Treatment Efficacy of Gastric
Helicobacter pylori
Eradication in Humans
. Polish Journal of Microbiology 71:2, pages 227-239.
Crossref
Crossref
Pavle Vrebalov Cindro, Josipa Bukić, Dario Leskur, Doris Rušić, Ana Šešelja Perišin, Joško Božić, Jonatan Vuković & Darko Modun. (2022) Helicobacter pylori Infection in Croatian Population: Knowledge, Attitudes and Factors Influencing Incidence and Recovery. Healthcare 10:5, pages 833.
Crossref
Crossref
Song-Ze Ding, Yi-Qi Du, Hong Lu, Wei-Hong Wang, Hong Cheng, Shi-Yao Chen, Min-Hu Chen, Wei-Chang Chen, Ye Chen, Jing-Yuan Fang, Heng-Jun Gao, Ming-Zhou Guo, Ying Han, Xiao-Hua Hou, Fu-Lian Hu, Bo Jiang, Hai-Xing Jiang, Chun-Hui Lan, Jing-Nan Li, Yan Li, Yan-Qing Li, Jie Liu, You-Ming LI, Bin Lyu, You-Yong Lu, Ying-Lei Miao, Yong-Zhan Nie, Jia-Ming Qian, Jian-Qiu Sheng, Cheng-Wei Tang, Fen Wang, Hua-Hong Wang, Jiang-Bin Wang, Jing-Tong Wang, Jun-Ping Wang, Xue-Hong Wang, Kai-Chun Wu, Xing-Zhou Xia, Wei-Fen Xie, Yong Xie, Jian-Ming Xu, Chang-Qing Yang, Gui-Bin Yang, Yuan Yuan, Zhi-Rong Zeng, Bing-Yong Zhang, Gui-Ying Zhang, Guo-Xin Zhang, Jian-Zhong Zhang, Zhen-Yu Zhang, Peng-Yuan Zheng, Yin Zhu, Xiu-Li Zuo, Li-Ya Zhou, Nong-Hua Lyu, Yun-Sheng Yang & Zhao-Shen Li. (2022)
Chinese Consensus Report on Family-Based
Helicobacter pylori
Infection Control and Management (2021 Edition)
. Gut 71:2, pages 238-253.
Crossref
Crossref
Guang Zhao, Zhishang Zhang, Baohui Li, Silin Huang, Wensi Li, ChaoYa Zhu, Bo Jiang, Songmao He, Yangkun Wang & Su’nan Wang. (2021)
Follow-up analysis and histopathological study of gastric mucosa in patients with
Helicobacter pylori
infection
. Journal of International Medical Research 49:12, pages 030006052110553.
Crossref
Crossref
Akiko Kowada. (2021) Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication. Digestive Diseases and Sciences 66:12, pages 4220-4226.
Crossref
Crossref
Akiko Kowada & Masahiro Asaka. (2021)
Economic and health impacts of introducing
Helicobacter pylori
eradication strategy into national gastric cancer policy in Japan: A cost‐effectiveness analysis
. Helicobacter 26:5.
Crossref
Crossref
Renliang Li, Ping Zhang, Ziyi HuYing Yi, Lisha Chen & Hengyi Zhang. (2021) Helicobacter pylori reinfection and its risk factors after initial eradication. Medicine 100:19, pages e25949.
Crossref
Crossref
Seyed Mohammad Sadegh Pezeshki, Najmadin Saki, Mehran Varnaseri Ghandali, Alireza Ekrami & Arshid Yousefi Avarvand. (2021)
Effect of
Helicobacter Pylori
eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East
. BLOOD RESEARCH 56:1, pages 38-43.
Crossref
Crossref
Anthony O'Connor, Takahisa Furuta, Javier P. Gisbert & Colm O'Morain. (2020)
Review – Treatment of
Helicobacter pylori
infection 2020
. Helicobacter 25:S1.
Crossref
Crossref
Linda Mezmale, Luiz Gonzaga Coelho, Dmitry Bordin & Marcis Leja. (2020)
Review: Epidemiology of
Helicobacter pylori
. Helicobacter 25:S1.
Crossref
Crossref
You Wu, Tun Su, Xianzhu Zhou, Nonghua Lu, Zhaoshen Li & Yiqi Du. (2020)
Awareness and attitudes regarding
Helicobacter pylori
infection in Chinese physicians and public population: A national cross‐sectional survey
. Helicobacter 25:4.
Crossref
Crossref
Gang Zhou. (2020)
Helicobacter pylori
Recurrence after Eradication Therapy in Jiangjin District, Chongqing, China
. Gastroenterology Research and Practice 2020, pages 1-6.
Crossref
Crossref